Trial Profile
On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxazosin (Primary) ; Ramipril (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 10 Sep 2016 Status changed from recruiting to completed.
- 23 Jul 2011 New trial record